Page last updated: 2024-09-03

sulbactam and Cholangitis

sulbactam has been researched along with Cholangitis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K1
Fujiwara, H; Hasegawa, N; Iwasaki, E; Iwata, S; Nishimura, T; Sugita, K; Uwamino, Y1
Huber, W; Kamereck, K; Prinz, C; Schmid, RM; Voland, P; Weber, A; Weidenbach, H; Winkle, P1
Dong, JH; Li, NF; Man, GT; Wu, WZ; Zeng, Z; Zhang, TL; Zhang, YD; Zhou, XS; Zou, SQ1
Amako, Y; Fujisaki, M; Hirano, M; Ishii, J; Itakura, M; Iwasa, T; Kako, M; Koyama, M; Mitamura, K; Nakaya, S; Nishio, T; Ohswawa, N; Ohyama, R; Okuda, K; Oohira, S; Saito, H; Shinagawa, N; Sugiyama, A; Takashima, S; Takeda, S; Ueda, M; Yamada, M; Yasuda, Y; Zeze, F1

Trials

2 trial(s) available for sulbactam and Cholangitis

ArticleYear
[Comparison of efficacy between ceftriaxone and cefoperazone plus sulbactam in peri-operative treatment of acute suppurative cholangitis].
    Zhonghua yi xue za zhi, 2004, Nov-17, Volume: 84, Issue:22

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefoperazone; Ceftriaxone; Cholangitis; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Perioperative Care; Postoperative Period; Prospective Studies; Sulbactam; Suppuration

2004
[Efficacy and safety of sulbactam/cefoperazone for hepato-biliary infections].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Cholangitis; Cholecystitis; Drug Combinations; Enterococcus; Female; Humans; Klebsiella Infections; Liver Abscess; Male; Middle Aged; Neoplasms; Pseudomonas Infections; Sulbactam; Treatment Outcome

1997

Other Studies

3 other study(ies) available for sulbactam and Cholangitis

ArticleYear
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
    Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2

    Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam

2017
The First Case Report of Acute Cholangitis and Bacteremia Due to Neisseria subflava.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:2

    Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cholangiocarcinoma; Cholangitis; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Humans; Male; Neisseria; Pancreaticoduodenectomy; Sulbactam; Tomography, X-Ray Computed

2017
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.
    World journal of gastroenterology, 2008, May-28, Volume: 14, Issue:20

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bile; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterococcus; Escherichia coli; Female; Fluoroquinolones; Humans; Klebsiella; Male; Middle Aged; Moxifloxacin; Piperacillin; Prospective Studies; Quinolines; Sulbactam

2008